{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:40:02Z","timestamp":1781934002592,"version":"3.54.5"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.3927","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T19:24:38Z","timestamp":1540581878000},"page":"e183927","source":"Crossref","is-referenced-by-count":31,"title":["Development and Assessment of Risk Scores for Carbapenem and Extensive \u03b2-Lactam Resistance Among Adult Hospitalized Patients With<i>Pseudomonas aeruginosa<\/i>Infection"],"prefix":"10.1001","volume":"1","author":[{"given":"Sara Y.","family":"Tartof","sequence":"first","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kuntz","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Center for Health Research, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie H.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Puzniak","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp, Kenilworth, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet S.","family":"Takhar","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Merchant","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp, Kenilworth, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lodise","sequence":"additional","affiliation":[{"name":"Albany College of Pharmacy and Health Sciences, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"issue":"8","key":"zoi180180r1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance.","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol"},{"issue":"4","key":"zoi180180r2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new \u00df-lactamases.","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi180180r3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/QCO.0b013e328303670b","article-title":"Clinically significant carbapenemases: an update.","volume":"21","author":"Walsh","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"zoi180180r4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi180180r5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/cid.2003.37.issue-6","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi180180r6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"zoi180180r7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"issue":"5","key":"zoi180180r8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.","volume":"244","author":"Leibovici","year":"1998","journal-title":"J Intern Med"},{"issue":"4","key":"zoi180180r9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"zoi180180r11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"issue":"2","key":"zoi180180r13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model.","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann Stat"},{"issue":"1","key":"zoi180180r15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the LASSO.","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc B"},{"issue":"10","key":"zoi180180r16","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"zoi180180r17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1086\/649021","article-title":"Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.","volume":"31","author":"Lautenbach","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"zoi180180r18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/432803","article-title":"Overview of nosocomial infections caused by gram-negative bacilli.","volume":"41","author":"Gaynes","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi180180r19","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1128\/AAC.01758-13","article-title":"A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.","volume":"58","author":"Voor In\u2019t Holt","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"zoi180180r20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0310057X1003800605","article-title":"Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.","volume":"38","author":"Furtado","year":"2010","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"zoi180180r21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/jac\/dkl327","article-title":"Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-\u00df-lactamase in two tertiary-care teaching hospitals.","volume":"58","author":"Zavascki","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"zoi180180r22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.","volume":"104","author":"Ohmagari","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"zoi180180r23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ajic.2008.05.016","article-title":"The evolution of drug-resistant microorganisms in patients with prolonged mechanical ventilation.","volume":"37","author":"Chien","year":"2009","journal-title":"Am J Infect Control"},{"issue":"5","key":"zoi180180r24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/aje\/kws241","article-title":"Mortality risk score prediction in an elderly population using machine learning.","volume":"177","author":"Rose","year":"2013","journal-title":"Am J Epidemiol"},{"key":"zoi180180r12","author":"Lund","year":"2017"},{"key":"zoi180180r10","unstructured":"World Health Organization, Department of Communicable Disease Surveillance and Response. WHO global strategy for containment of antimicrobial resistance. http:\/\/www.who.int\/csr\/resources\/publications\/drugresist\/en\/EGlobal_Strat.pdf. Accessed December 30, 2016."},{"key":"zoi180180r14","unstructured":"JohnstonG, RodriguezRN. Introducing the HPGENSELECT Procedure: Model Selection for Generalized Linear Models and More: Paper SAS1742-2015.https:\/\/support.sas.com\/resources\/papers\/proceedings15\/SAS1742-2015.pdf. Accessed January 2017."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/6\/e183927\/17298896\/tartof_2018_oi_180180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T20:30:08Z","timestamp":1720729808000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.3927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,10,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3927","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]}}}